Trendingnow
Commentary
Ideas and insights on pressing issues facing the business world.

By James G. Naples, Wendy K. Smith and Scott D. AnthonyJune 27, 2026
Latest Stories
More CommentaryPage 36 of 100

CommentaryThe most underreported and important story in AI right now is that pure scaling has failed to produce AGI
By Gary MarcusFebruary 19, 2025

By Mauro MacchiFebruary 18, 2025

CommentaryElon Musk wants the U.S. Treasury to be on a blockchain. That’s a terrible idea—take it from a big proponent of the technology
By Nic PuckrinFebruary 14, 2025

By Iman PabaniFebruary 14, 2025

CommentaryThe best psych-out artists know how to mess with your mind, but Trump’s push for tariffs shows how this strategy can backfire
By Bob BrodyFebruary 13, 2025

CommentaryThe Trump admin will encourage—not hinder—U.S. leadership in blockchain technology and cryptocurrency. We must seize the moment
By Chase ErgenFebruary 13, 2025

By Amit WaliaFebruary 12, 2025

By Bob SternfelsFebruary 11, 2025

By Jeffrey Sonnenfeld, Stephen Henriques and Steven TianFebruary 11, 2025

CommentaryAt 18 we cold-pitched Etihad on upending air miles. It worked, and 3 years later we’ve raised $1.5M to transform travel loyalty programs
By Harvey Lowe and Prithveesh ReddyFebruary 11, 2025

CommentaryAI ‘prompt and pray’ hasn’t cut it in the enterprise, but we’ve found the missing puzzle piece. Mass deployment is next
By Yoav ShohamFebruary 10, 2025

CommentaryFor the U.S. to maintain tech supremacy, it must embrace decentralization and open source AI
By Jake BrukhmanFebruary 8, 2025

CommentaryH-1B visa debates roil U.S.-India relations ahead of Trump-Modi meeting. Here’s what needs to change—on both sides
By Angela Chitkara and Curtis S. ChinFebruary 7, 2025

By François Candelon, Theodoros Evgeniou, Leonid Zhukov, Meenal Pore and Amartya DasFebruary 7, 2025

By Tracy ChouFebruary 6, 2025

By Mark PennFebruary 6, 2025

CommentaryThe faulty forecasts of pharma firm investors: Misguided cynics miss the promising prognosis for drugmakers Pfizer and Merck
By Jeffrey Sonnenfeld and Steven TianFebruary 5, 2025

By Alyson ShontellFebruary 4, 2025

By Edwin OlsonFebruary 4, 2025

By Michael DunneFebruary 4, 2025

By Arvind KrishnaFebruary 4, 2025

By Wil SchroterFebruary 3, 2025

By Selina XuJanuary 31, 2025

CommentaryI’m a refugee-turned-entrepreneur and Oxford professor. Here’s what we can all learn from the immigrant entrepreneurs who make America great
By Neri Karra SillamanJanuary 31, 2025

CommentaryThere’s a glaring inequitable gender experience in America’s C-suite—and it’s hurting companies
By Fresia Jackson and Heather WalkerJanuary 30, 2025

CommentaryTech giants, not unicorns, lead the race to deliver on AI’s promise—and they’re reshaping finance to do it
By Andrew Moore and Johannes LangJanuary 30, 2025
Most Popular






















